A k-mer based transcriptomics approach for antisense drug discovery targeting the Ewing's family of tumors
Page 1 of 1
A k-mer based transcriptomics approach for antisense drug discovery targeting the Ewing's family of tumors
Jon Moulton Mon Aug 13, 2018 3:06 pm
Annalora AJ, O'Neil S, Bushman JD, Summerton JE, Marcus CB, Iversen PL. A k-mer based transcriptomics approach for antisense drug discovery targeting the Ewing's family of tumors. Oncotarget. 2018 Jul 17;9(55):30568-30586. doi: 10.18632/oncotarget.25736. eCollection 2018 Jul 17.
Jon Moulton- Posts : 5721
Join date : 2010-03-12
Age : 62
Location : Philomath, Oregon, USA -
Similar topics» A Dominant Negative Antisense Approach Targeting β-Catenin
» Antisense targeting of 3'end elements involved in DUX4 mRNA processing is an efficient therapeutic strategy for Facioscapulohumeral Dystrophy: a new gene silencing approach
» Induced IL-10 Splice Altering Approach to Antiviral Drug Discovery
» Antisense Antibiotics: A Brief Review of Novel Target Discovery and Delivery
» Antisense modulation of RNA processing as a therapeutic approach in cancer therapy
» Antisense targeting of 3'end elements involved in DUX4 mRNA processing is an efficient therapeutic strategy for Facioscapulohumeral Dystrophy: a new gene silencing approach
» Induced IL-10 Splice Altering Approach to Antiviral Drug Discovery
» Antisense Antibiotics: A Brief Review of Novel Target Discovery and Delivery
» Antisense modulation of RNA processing as a therapeutic approach in cancer therapy
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum